Type 1 Diabetes Extension Study (T1DES)
Children's Health | Diabetes Mellitus - Type 1
What is the purpose of this trial?
To further our understanding of the immunologic mechanisms underlying maintenance and loss of beta cell function by evaluating the relationship between longitudinal changes in beta cell function and changes over time in biomarkers known to be associated with a response to immune modulating treatments which were used in prior clinical trials (Refer to ClinicalTrials.gov records NCT00129259 and NCT00965458).
- Ages8 years - 35 years
- Trial withBenaroya Research Institute
- Start Date05/06/2016
- End Date03/01/2021
- Last Updated07/15/2021
- Study HIC#1512016925